Skip to main content
Premium Trial:

Request an Annual Quote

$120 Billion Bill Moves Along

The US Senate voted this week to advance a bill that would invest $120 billion in science with the aim of increasing competitiveness against China, the New York Times reports.

"If we're going to win the next century, the United States needs to be the one discovering the next groundbreaking technologies," Senator Chuck Schumer (D-NY), a bill sponsor and Senate majority leader, tells the Times.

The bill, called the Endless Frontiers Act, includes $100 billion in funding for a new technology directorate at the National Science Foundation, Politico says. It adds, though, that the Senate Commerce Committee adopted an amendment to the bill that would instead shift some of those funds to labs run by the Department of Energy. Senator Todd Young (R-Ind.), a co-sponsor of the bill, tells Politico that that change could cost the bill some Republican support, though he is hopeful that a compromise could be reached.

The Times adds that Young has additionally argued that the bill should focus on applied research, but other lawmakers have pushed for funds to go to labs in their home states and districts that perform basic research.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.